AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35362378 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (INT) - Nurse-led and interdisciplinary cardiovascular prevention and rehabilitation programme (CVPRP) for 16 weeks
Number of subjects: 6
Study 35362378 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 6
Study 34393491 — intervention group
Group type: EXPERIMENTAL
Intervention: 4As model (facility-based counseling)
Number of subjects: 0
Study 34393491 — intervention group
Group type: EXPERIMENTAL
Intervention: 4As + R model (home-based counseling)
Number of subjects: 0
Study 34393491 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive activities (non-delivery cost)
Number of subjects: 0
Study 34393491 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cost per smoker
Number of subjects: 0
Study 33129099 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-curcumin
Number of subjects: 40
Study 33129099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 35389288 — intervention group
Group type: EXPERIMENTAL
Intervention: Level 3: Levels 1-2 plus Fitbit and text messages
Number of subjects: 202
Study 35389288 — intervention group
Group type: COMPARATOR
Intervention: Level 2: Level 1 plus personalized diet and exercise prescription
Number of subjects: 202
Study 35389288 — intervention group
Group type: COMPARATOR
Intervention: Level 1: website
Number of subjects: 202
Study 35389288 — intervention group
Group type: COMPARATOR
Intervention: Level 4: Levels 1-3 plus 2 30-minute coaching calls
Number of subjects: 202
Study 32898698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-lidocaine group (0.5 mg/kg ketamine plus 1 mg/kg lidocaine)
Number of subjects: 44
Study 32898698 — intervention group
Group type: COMPARATOR
Intervention: Ketamine group (1 mg/kg ketamine)
Number of subjects: 44
Study 32898698 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine-lidocaine group
Number of subjects: 44
Study 32898698 — intervention group
Group type: COMPARATOR
Intervention: Ketamine group
Number of subjects: 44
Study 32898698 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study 32947595 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate fixation
Number of subjects: 166
Study 32947595 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 166
Study 35104171 — intervention group
Group type: EXPERIMENTAL
Intervention: My Life After Stroke (MLAS) self-management programme
Number of subjects: 17
Study 35104171 — intervention group
Group type: EXPERIMENTAL
Intervention: MLAS self-management programme
Number of subjects: 17
Study 33894834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonelokimab 30 mg
Number of subjects: 313
Study 33894834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonelokimab 60 mg
Number of subjects: 313
Study 33894834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonelokimab 120 mg normal load
Number of subjects: 313
Study 33894834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonelokimab 120 mg augmented load
Number of subjects: 313
Study 33894834 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 313
Study 33894834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study 34051117 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography during coronary artery bypass graft surgery
Number of subjects: 0
Study 34051117 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33310293 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant systemic therapy (NST)
Number of subjects: 206
Study 33310293 — intervention group
Group type: COMPARATOR
Intervention: Standard neoadjuvant treatment or experimental treatment modified according to interim Ki-67 evaluation
Number of subjects: 206
Study 32066739 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (1 Hz)
Number of subjects: 0
Study 32066739 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0
Study 36180158 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training with gaze stabilization exercises
Number of subjects: 64
Study 36180158 — intervention group
Group type: COMPARATOR
Intervention: Balance training with saccade eye exercises (control group)
Number of subjects: 64
Study 34506240 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine 30 mg/acetaminophen 325 mg every 4 hours as needed for severe pain for 4 days
Number of subjects: 200
Study 34506240 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone 5 mg/acetaminophen 325 mg every 4 hours as needed for severe pain for 4 days
Number of subjects: 200
Study 34506240 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (codeine and oxycodone)
Number of subjects: 200
Study 34246994 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 1118
Study 34246994 — intervention group
Group type: COMPARATOR
Intervention: Microscopic surgery
Number of subjects: 1118
Study 33092705 — intervention group
Group type: EXPERIMENTAL
Intervention: MitraClip implantation
Number of subjects: 613
Study 33092705 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 613
Study 35265234 — intervention group
Group type: EXPERIMENTAL
Intervention: UTVOR (volatile oil of Olibanum and volatile oil of Chuanxiong Rhizoma with ultrasound therapy)
Number of subjects: 116
Study 35265234 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasound therapy
Number of subjects: 116
Study 35265234 — intervention group
Group type: EXPERIMENTAL
Intervention: UTVOR
Number of subjects: 116
Study 36197757 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg
Number of subjects: 381
Study 36197757 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozoralizumab 80 mg
Number of subjects: 381
Study 36197757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 381
Study 36197757 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozoralizumab 30 mg and 80 mg
Number of subjects: 381
Study 32048133 — intervention group
Group type: EXPERIMENTAL
Intervention: High lactate levels (≥ 2 mmol/l)
Number of subjects: 85
Study 32048133 — intervention group
Group type: COMPARATOR
Intervention: Low lactate levels (< 2 mmol/l)
Number of subjects: 85
Study 33322963 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group received directly observed therapy of asthma controller medication, medication adjustments, and daily self-management support.
Number of subjects: 29
Study 33322963 — intervention group
Group type: COMPARATOR
Intervention: Usual care group referred back to primary care provider for routine asthma care.
Number of subjects: 29
Study 33322963 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups had significant improvements in Asthma Control Test scores from baseline to 7 month follow-up (both p <.01).
Number of subjects: 29
Study 33322963 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 29
Study 32602552 — intervention group
Group type: EXPERIMENTAL
Intervention: AGGF1 expression in preeclamptic placentas
Number of subjects: 28
Study 32602552 — intervention group
Group type: COMPARATOR
Intervention: AGGF1 expression in normotensive control placentas
Number of subjects: 28
Study 36266396 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (right DLPFC anodal stimulation)
Number of subjects: 80
Study 36266396 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (Sensorimotor Rhythm protocol)
Number of subjects: 80
Study 36266396 — intervention group
Group type: COMPARATOR
Intervention: Active neuromodulation (tDCS or neurofeedback)
Number of subjects: 80
Study 36266396 — intervention group
Group type: COMPARATOR
Intervention: Sham neuromodulation (placebo)
Number of subjects: 80
Study 34051009 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut microbiota profile analysis using 16S rRNA gene sequencing in high-risk group (men with Grade group 2 or higher PCa)
Number of subjects: 152
Study 34051009 — intervention group
Group type: EXPERIMENTAL
Intervention: Index calculated from the abundance of 18 bacterial genera
Number of subjects: 152
Study 34051009 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation of the index in the test cohort
Number of subjects: 152
Study 34772609 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (capecitabine, oxaliplatin added an investigator's choice)
Number of subjects: 231
Study 34772609 — intervention group
Group type: COMPARATOR
Intervention: Follow-up (control group)
Number of subjects: 231
Study 34162198 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine gluconate mouthrinse gargled for 1 minute before EBUS‐TBNA
Number of subjects: 112
Study 34162198 — intervention group
Group type: COMPARATOR
Intervention: No mouthrinse before EBUS‐TBNA
Number of subjects: 112
Study 33157007 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid genomic sequencing (RGS)
Number of subjects: 201
Study 33157007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-rapid whole-genome sequencing (urWGS)
Number of subjects: 201
Study 33157007 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive tests
Number of subjects: 201
Study 34126264 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 37
Study 34126264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 33793609 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation with virtual reality using the Wii® console, Wii-Remote and Wii Balance Board, performing balance games for 30 minutes to an hour, twice a week for 10 weeks (total: 20 sessions).
Number of subjects: 40
Study 33793609 — intervention group
Group type: COMPARATOR
Intervention: Vestibular rehabilitation with virtual reality using the Wii® console, Wii-Remote and Wii Balance Board, performing balance games and muscle strength games for 30 minutes to an hour, twice a week for 10 weeks (total: 20 sessions).
Number of subjects: 40
Study 34010932 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegteograstim
Number of subjects: 32
Study 32343641 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Number of subjects: 1014
Study 35949961 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy (8 Hz, 3.2 mT) in addition to a conventional rehabilitation program
Number of subjects: 32
Study 35949961 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program (physical modalities, exercises, and occupational therapy)
Number of subjects: 32
Study 34028859 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led dietary diabetes insipidus (DI) bundle
Number of subjects: 50
Study 33949332 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal stenting of the pancreaticojejunostomy anastomosis (Group B)
Number of subjects: 50
Study 33949332 — intervention group
Group type: COMPARATOR
Intervention: No internal stenting of the pancreaticojejunostomy anastomosis (Group A)
Number of subjects: 50
Study 33078386 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine at 0.2 mg/kg/d, titrated to a maximum of 0.7 mg/kg/d (or 0.4 mg/kg/d with stiripentol)
Number of subjects: 232
Study 33078386 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 232
Study 34152940 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with Work and Family Stress (CWFS) evidence‐based curriculum
Number of subjects: 0
Study 34152940 — intervention group
Group type: COMPARATOR
Intervention: Control group (no programming)
Number of subjects: 0
Study 33511717 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of amino acid sequence and local structure relationships
Number of subjects: 4000
Study 616517889 — intervention group
Group type: EXPERIMENTAL
Intervention: High-pitch spiral dual-source CT acquisition (group A)
Number of subjects: 50
Study 616517889 — intervention group
Group type: COMPARATOR
Intervention: Retrospectively gated spiral dual-source CT acquisition (group B)
Number of subjects: 50
Study 32267588 — intervention group
Group type: EXPERIMENTAL
Intervention: image‐and‐text HWL
Number of subjects: 6024
Study 32267588 — intervention group
Group type: EXPERIMENTAL
Intervention: image‐only HWL
Number of subjects: 6024
Study 32267588 — intervention group
Group type: EXPERIMENTAL
Intervention: text‐only HWL
Number of subjects: 6024
Study 32267588 — intervention group
Group type: COMPARATOR
Intervention: no HWL
Number of subjects: 6024
Study 34252783 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment for youth with co-occurring mental health and substance use concerns
Number of subjects: 110
Study 32736330 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised decision support systems (CDSSs)
Number of subjects: 29
Study 35124650 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF markers of CNS barrier disruption, cerebrovascular dysfunction, CSF inflammatory cytokines, blood lipid profiles
Number of subjects: 0
Study 35124650 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood lipid profiles
Number of subjects: 0
Study 35124650 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning prediction model
Number of subjects: 0
Study 34999143 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroactive memory interference (RI) group
Number of subjects: 0
Study 34999143 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34999143 — intervention group
Group type: EXPERIMENTAL
Intervention: Guilty group (both RI and control)
Number of subjects: 0
Study 33977687 — intervention group
Group type: EXPERIMENTAL
Intervention: Arjun Chāl (Terminalia arjuna) 5 gm BD for 8 weeks
Number of subjects: 48
Study 33977687 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (5 mg) and Atorvastatin (10 mg) once a day for 8 weeks
Number of subjects: 48
Study 35254473 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser (LS)
Number of subjects: 114
Study 35254473 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF)
Number of subjects: 114
Study 35254473 — intervention group
Group type: COMPARATOR
Intervention: Sham Control (SCT)
Number of subjects: 114
Study 35254473 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser (LS) and Radiofrequency (RF)
Number of subjects: 114
Study 32143674 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive conjunctive cognitive training (ACCT)
Number of subjects: 30
Study 32143674 — intervention group
Group type: COMPARATOR
Intervention: Standard cognitive tasks (Control)
Number of subjects: 30
Study 34248001 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel treatment
Number of subjects: 0
Study 34248001 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 33417897 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic hemoclip application
Number of subjects: 204
Study 33417897 — intervention group
Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 204
Study 32219973 — intervention group
Group type: EXPERIMENTAL
Intervention: GI2 kHz/2 Hz
Number of subjects: 175
Study 32219973 — intervention group
Group type: EXPERIMENTAL
Intervention: GI4 kHz/2 Hz
Number of subjects: 175
Study 32219973 — intervention group
Group type: EXPERIMENTAL
Intervention: GI4 kHz/100 Hz
Number of subjects: 175
Study 32219973 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PG)
Number of subjects: 175
Study 35793884 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with western medication
Number of subjects: 60
Study 35793884 — intervention group
Group type: COMPARATOR
Intervention: Western medication
Number of subjects: 60
Study 34279749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combination carteolol/latanoprost (LCFC)
Number of subjects: 22
Study 34279749 — intervention group
Group type: COMPARATOR
Intervention: Timolol/latanoprost (LTFC)
Number of subjects: 22
Study 35970016 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,2,3,emoció! program
Number of subjects: 2625
Study 35970016 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 2625
Study 34383762 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component school-based intervention to prevent intimate partner violence
Number of subjects: 3743
Study 34383762 — intervention group
Group type: EXPERIMENTAL
Intervention: Low family socio-economic status (SES)
Number of subjects: 3743
Study 34383762 — intervention group
Group type: EXPERIMENTAL
Intervention: Learner behavior, home environment, and school environment
Number of subjects: 3743
Study 34322126 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide pools derived from HCMV
Number of subjects: 48
Study 34322126 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide pools derived from HAdV
Number of subjects: 48
Study 32015461 — intervention group
Group type: EXPERIMENTAL
Intervention: AVL-3288 (10 mg)
Number of subjects: 24
Study 32015461 — intervention group
Group type: EXPERIMENTAL
Intervention: AVL-3288 (30 mg)
Number of subjects: 24
Study 32015461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 35697217 — intervention group
Group type: EXPERIMENTAL
Intervention: Trailbridges
Number of subjects: 147
Study 33626615 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/syphilis joint self‐testing group
Number of subjects: 145
Study 33626615 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery incentive self‐testing group
Number of subjects: 145
Study 33626615 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 145
Study 32665162 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan + Furosemide
Number of subjects: 40
Study 32665162 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 40
Study 36301170 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupotomy
Number of subjects: 90
Study 36301170 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm needling
Number of subjects: 90
Study 36301170 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (acupotomy + warm needling)
Number of subjects: 90
Study 34936267 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal penetration needling at vertigo auditory area and balance area (treatment given once every other day for two courses of treatment)
Number of subjects: 66
Study 34936267 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture and medication)
Number of subjects: 66
Study 33969800 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical depression
Number of subjects: 2608
Study 33969800 — intervention group
Group type: EXPERIMENTAL
Intervention: Distress
Number of subjects: 2608
Study 33969800 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicidal thoughts
Number of subjects: 2608
Study 33969800 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported anxiety, depressive thoughts, suicidal ideation, and being currently depressed/distressed
Number of subjects: 2608
Study 33969800 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective factors
Number of subjects: 2608
Study 35742754 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleaved micro‐lectures by both perceptual modality and subject matter (I-all condition)
Number of subjects: 81
Study 35742754 — intervention group
Group type: COMPARATOR
Intervention: Blocked micro‐lectures with auditory textual information (B-A condition)
Number of subjects: 81
Study 35742754 — intervention group
Group type: COMPARATOR
Intervention: Blocked micro‐lectures with visual textual information (B-V condition)
Number of subjects: 81
Study 35742754 — intervention group
Group type: COMPARATOR
Intervention: Interleaved micro‐lectures with auditory textual information (I-A condition)
Number of subjects: 81
Study 34037290 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.1 mg/kg)
Number of subjects: 100
Study 33244344 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal Health Services (MHS) utilization
Number of subjects: 212
Study 33244344 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of stigmatisation
Number of subjects: 212
Study 33244344 — intervention group
Group type: EXPERIMENTAL
Intervention: MHS utilization based on marital status
Number of subjects: 212
Study 33244344 — intervention group
Group type: COMPARATOR
Intervention: MHS utilization and maternal education
Number of subjects: 212
Study 33244344 — intervention group
Group type: COMPARATOR
Intervention: MHS utilization and availability/accessibility of MHS facilities
Number of subjects: 212
Study 33244344 — intervention group
Group type: COMPARATOR
Intervention: MHS utilization and cost of MHS
Number of subjects: 212
Study 33244344 — intervention group
Group type: COMPARATOR
Intervention: MHS utilization and coercion/violence from partner
Number of subjects: 212
Study 32238301 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional RGP CL
Number of subjects: 28
Study 32238301 — intervention group
Group type: EXPERIMENTAL
Intervention: Kerasoft CL
Number of subjects: 28
Study 32238301 — intervention group
Group type: EXPERIMENTAL
Intervention: Rose K2 CL
Number of subjects: 28
Study 32238301 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral RGP CL
Number of subjects: 28
Study 32238301 — intervention group
Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 28
Study 32238301 — intervention group
Group type: COMPARATOR
Intervention: Controls (10 age‐matched controls)
Number of subjects: 28
Study 36138354 — intervention group
Group type: EXPERIMENTAL
Intervention: Goggles + surgical mask
Number of subjects: 52
Study 36138354 — intervention group
Group type: EXPERIMENTAL
Intervention: Face shield + surgical mask
Number of subjects: 52
Study 36138354 — intervention group
Group type: EXPERIMENTAL
Intervention: Half‐face respirator
Number of subjects: 52
Study 36138354 — intervention group
Group type: EXPERIMENTAL
Intervention: Full‐face respirator
Number of subjects: 52
Study 36138354 — intervention group
Group type: COMPARATOR
Intervention: Conventional PPE (goggles + surgical mask, face shield + surgical mask)
Number of subjects: 52
Study 32554067 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg bolus over 10 minutes, followed by 0.5 μg/kg per hour maintenance) with midazolam (0.03 mg/kg)
Number of subjects: 141
Study 32554067 — intervention group
Group type: COMPARATOR
Intervention: Propofol (125 μg/kg per minute infusion over 10 minutes with intraoperative boluses of 0.1 μg/kg) and fentanyl (0.8 μg/kg) with midazolam (0.03 mg/kg)
Number of subjects: 141
Study 32554067 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and midazolam
Number of subjects: 141